GFR Estimation, Hull
The Hull GFR equation estimates kidney function using creatinine while adjusting for age and body size to improve accuracy in chronic kidney disease.
Indikationen
Used for estimating kidney function when creatinine-based eGFR is unreliable due to altered creatinine generation (low muscle mass, liver disease, malnutrition). Helps guide CKD staging and drug‑dosing decisions when standard eGFRcr is inaccurate, aligning with KDIGO emphasis on assessing non‑GFR determinants before relying on creatinine alone (KDIGO 2024 1). Clinical utility: improves individual-level GFR estimation where precision affects management (KDIGO 2024 2).
Hinweise & Vorsichtsmaßnahmen
Avoids race-based terms, relies on creatinine alone, and is prone to error in non–steady-state kidney function or altered muscle mass. Accuracy is lower than equations combining creatinine and cystatin C, which achieve P30 ≈90% in large external validations 1. KDIGO 2024 cautions that creatinine-only equations are unreliable in extremes of muscle mass, inflammation, cirrhosis, cancer, or steroid use, advising eGFRcr‑cys or measured GFR when clinical decisions require precision 2.